A prospective study to evaluate efficacy of rituximab efficacy in the treatment of children with chronic immune thrombocytopenic purpura.
Phase of Trial: Phase II
Latest Information Update: 23 Nov 2015
At a glance
- Drugs Rituximab (Primary)
- Indications Immune thrombocytopenic purpura
- Focus Therapeutic Use
- 23 Nov 2015 New trial record